Skip to content

Effect of cipofol versus propofol on dreams and mood during gastroscopy: a single-center randomized controlled trial

Effect of cipofol versus propofol on dreams and mood during gastroscopy: a single-center randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082655
Enrollment
Unknown
Registered
2024-04-02
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless gastroenteroscopy

Interventions

Propofol group:For anesthetic induction, 0.1µg/kg of sufentanil and 1.5mg/kg of propofol were used. If the induced dose did not meet the adequate standard for sedation, 0.75 mg/kg of propofol was adde
Ciprofol group:For anesthetic induction, 0.1µg/kg sufentanil and 0.4mg/kg ciprofol were used. If the induced dose did not meet the adequate standard for sedation, 0.15 mg/kg ciprofol was added during

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for gastroscopy; Age 18-65 years old; The ASA rating is I-III.

Exclusion criteria

Exclusion criteria: About to receive a tracheal tube or laryngeal mask; Recent use of sedatives or analgesics; A history of allergy to opioids, propofol, or ciprofol ingredients (e.g., soybean oil, glycerin, triglyceride, yolk lecithin, sodium oleate, and sodium hydroxide); Acute heart failure, unstable angina pectoris, myocardial infarction within 6 months prior to screening, resting electrocardiogram (ECG) heart rate <50 beats/min, grade III atrioventricular block, severe arrhythmia, moderate to severe heart valve disease; Have other severe respiratory diseases, such as acute respiratory infections, acute episodes of chronic obstructive pulmonary disease, uncontrolled asthma, etc.; Mental illness (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term use of psychotropic substances, and cognitive impairment; Severe hepatic and renal insufficiency; Pregnancy or lactation; Participate in other clinical trials within the last 3 months; Patients undergoing gastroscopy combined with colonoscopy or gastroscopy.

Design outcomes

Primary

MeasureTime frame
Incidence of quality dreams during sedation in both groups;Positive and negative emotional scores(PANAS) after awakening in both groups;

Secondary

MeasureTime frame
Sedation success rates in both groups;Vital signs and BIS data at time of administration (T1), time of adequate sedation/gastroscopy start (T2), time of examination completion (T3);Patient satisfaction score;

Countries

China

Contacts

Public ContactZhong Tao

Xiangya Hospital, Central South University

Zhongtao-csu@qq.com+86 139 7482 0727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026